maxgraft® Blöcke: Eine retrospektive Studie über 12 Monate
Vergleich von allogenen und autologen Blöcken zur Kieferkammaugmentation – eine retrospektive radiografische Untersuchung über 12 Monate Kloss
03 November, 2018maxgraft®: 3- up to 8-year retrospective study
The use of mineralized bone allograft (C+TBA) as a single grafting material in maxillary sinus lifting with severely atrophied alveolar ridge (1–3mm)
14 August, 2018New preclinical study analyzed the bone graft integration and angiogenesis after augmentation with cerabone®
Inflammatory-driven angiogenesis in bone augmentation with bovine hydroxyapatite, B-tricalcium phosphate and Bioglasses. Comparative study. Anghelescu
14 August, 2018New study on periimplant soft tissue augmentation with mucoderm®
The Use of a Novel Porcine Derived Acellular Dermal Matrix (mucoderm) in Peri-Implant Soft Tissue Augmentation: Preliminary Results of a Prospective P
17 July, 2018New clinical study on 30 patients demonstrates the excellent osteoconductive potential of cerabone®
Goal: The aim of the study was to histologically determine the role of the repositioned lateral bone window in bone maturation in sinus lift procedure
07 July, 2018Straumann Group acquires 30% stake in botiss
botiss benefits from Straumann’s global distribution and supply network, regulatory resources, and strength as a total solution provider Companies to
04 July, 2018New study on collprotect® membrane – successful application in the treatment of dehicence defects
Effect of deproteinized bovine bone mineral at implant dehiscence defects grafted by the sandwich bone augmentation technique. Shih-Cheng Wen, Jia-Hu
20 April, 2018New publication demonstrated good physico-chemical properties of cerabone®, maxresorb® and maxgraft®
Trajkovski et al. Hydrophilicity, Viscoelastic, and Physicochemical Properties Variations in Dental Bone Grafting Substitutes. Materials 2018, 11, 215
21 February, 2018STUDY: Significantly higher volume stability of maxresorb® compared to pure beta-TCP
Jelusic et al. Monophasic ß-TCP vs. biphasic HA/ß-TCP in two-stage sinus floor augmentation procedures – a prospective randomized clinical trial. Clin
20 February, 2018STUDY: Long-term stable functional and aesthetic results following implantation and simultaneous GBR with maxresorb®
Lorenz et al. Investigation of peri-implant tissue conditions and peri-implant tissue stability in implants placed with simultaneous augmentation proc
20 February, 2018STUDY: mucoderm® for thickening of the peri-implant soft tissue
Zafiropoulos et al. Changes of the peri‑implant soft tissue thickness after grafting with a collagen matrix. J Indian Soc Periodontol. 2016 Jul-Aug;20
20 February, 2018STUDY: mucoderm® for the treatment of multiple recession type defects I and II
Vincent-Bugnas et al. Treatment of multiple maxillary adjacent class I and II gingival recessions with modified coronally advanced tunnel and a new xe
20 February, 2018STUDY: maxresorb® inject serves as an excellent carrier for growth factors
Fujioka-Kobayashi et al. In vitro evaluation of an injectable biphasic calcium phosphate (BCP) carrier system combined with recombinant human bone mor
16 February, 2018New indication for maxgraft® bonebuilder: First report worldwide about custom-milled allogeneic bone grafts for alveolar cleft osteoplasty
Otto S, et al., Custom-milled individual allogeneic bone grafts for alveolar cleft osteoplasty – A technical note, Journal of Cranio-Maxillo-Fac
24 October, 2017botiss is partner company of Médecins sans Frontières in 2017
Médecins Sans Frontières provides assistance to populations in distress, to victims of natural or man-made disasters and to victims of armed conflict.
02 August, 2017NEW PUBLICATION:
The comprehensive study of the group of Prof. Kasaj confirms that mucoderm can be used as a carrier of bioactive fluids (Emdogain® and PRF®) to improv
22 July, 2017permamem®: new synthetic barrier membrane for the regeneration of dental bone defects
With the introduction of permamem®, botiss expands its regeneration system by offering an exceptionally thin, non-resorbable, biologically inert and b
14 July, 2017> 20 ARTICLES in 2016
Last year more than 20 scientific articles were published on botiss’ hard and soft tissue products. Among the most recent ones, have a look at t
06 January, 2017cerabone®: New study
A new study about a sinus floor elevation method has recently been published in the International Journal of Oral & Maxillofacial Implants, where
20 December, 2016maxresorb® – a bone graft material with striking properties!
A recent study from the group of Prof. Miron of the College of Dental Medicine, at the Nova Southeastern University, FL (USA), confirmed the following
19 December, 2016Expert Meeting – mucoderm® REVIEW
On November the 25th, the 2nd mucoderm® expert meeting has taken place in Hamburg, Germany. The aim of the meeting was to review the currently availab
16 December, 2016collacone®: New study
A new study about a novel liquid carrier system for enamel matrix proteins in combination with collacone® has recently been published: Miron RJ, Fujio
13 December, 2016Expert meeting – mucoderm®
Parallel to the DGI annual meeting, the second expert meeting on mucoderm® will take place in Hamburg on 25.11. The group of international renowned cl
16 November, 2016- 24 October, 2016
EAO | 5 dental minutes
Watch the Interview about the bone & tissue days Berlin 2016 with our Director International Sales & Marketing at botiss, Zoltan Kasap, at the
21 October, 2016bone & tissue days 2016
bone & tissue days 2016 / World Congress Berlin It was a great, and exciting congress with high level education. THANKS to everyone
15 September, 2016Our 3rd bone & tissue days / World Congress takes place in Berlin
We are proud to organize and host the 3rd bone & tissue days / World Congress this September 8 – 10, 2016. This year’s congress will be held
02 September, 2016Welcome to our Team: Dr. Mike Barbeck & Jacek Suchan
Since 1st of July Dr. Mike Barbeck is working for botiss in Berlin. He is responsible member of the product management team and specially in charge of
31 August, 2016Jason® fleece/collacone®: interesting clinical study published
by Zirk and colleagues: Prevention of post-operative bleeding in hemostatic compromised patients using native porcine collagen fleeces-retrospective s
10 June, 2016cerabone®: interesting clinical study published
by Fienitz and colleagues: Histological and radiological evaluation of sintered and non-sintered deproteinized bovine bone substitute materials in sin
04 June, 2016The Press release to the bone & tissue days / World Congress Berlin 2016 was published
The press release to the 3rd bone & tissue days / World Congress Berlin 2016 was published. After that we started inviting our media partner and p
02 June, 2016We welcome two new colleagues to our team
After Alba Simon’s departure from botiss, the International Sales team has incorporated a new member, Maria Genua, to take over the countries in Weste
01 June, 2016botiss is Gold Sponsor at the Osteology in Monaco
Gold sponsor botiss biomaterials celebrated its premiere at the Osteology and convinced with an innovative booth concept earning a lot of interested l
04 April, 2016This website is for you!
As an innovative company, we need innovative websites. We set up a completely new version of each website, to facilitate the application for YOU. Toge
01 February, 2016Older news
Exciting news and botiss´ activities from the past years can be found on our facebook-page.
03 January, 2016
